Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Standalone and Consolidated ....
IPCALAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ipca Laboratories has informed stock exchanges that its Board of Directors will meet on Friday, 13 February 2026 to consider and approve the Standalone and Consolidated Unaudited Financial Results for the third quarter and nine months ended 31 December 2025. This is a standard regulatory filing under SEBI's Listing Obligations and Disclosure Requirements. The company's insider trading window remains closed from 1 January 2026 until 48 hours after the results are declared, i.e., 15 February 2026. No financial figures, projections, or business commentary are disclosed in this notice.
This is a routine pre-results intimation with no material new information for investors. Shareholders should watch for the actual Q3 results announcement on or after 13 February 2026, which may move the stock based on earnings performance and management commentary.